Replimune (REPL) Amortizatization of Intangibles (2024 - 2026)
Replimune (REPL) posted Amortizatization of Intangibles of $607000.0 for Q1 2026, little changed sequentially from $607000.0 in Q4 2025, and little changed YoY from $607000.0 in Q1 2025.
Powered by 
Analysis
Replimune (REPL) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Replimune has reported Amortizatization of Intangibles for 3 years, with the latest figure at $607000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles changed 0.0% year-over-year to $607000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (changed 0.0% YoY) and the FY2026 annual result came in at $2.4 million, changed 0.0% from the prior year.
- Amortizatization of Intangibles steadied at $607000.0 in Q1 2026 per REPL's latest filing, from $607000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $607000.0 in Q2 2024 and troughed at $607000.0 in Q2 2024.
- A 3-year average of $607000.0 and a median of $607000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 0.0% in 2025, down 0.0% in 2025.
- Over 3 years, Amortizatization of Intangibles stood at $607000.0 in 2024, then changed by 0.0% to $607000.0 in 2025, then changed by 0.0% to $607000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $607000.0, $607000.0, and $607000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Replimune | 1.46 Bn | 1.46 Bn | - | 607,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 607,000.00 |
| Mar 31, 2026 | 607,000.00 |
| Dec 31, 2025 | 607,000.00 |
| Sep 30, 2025 | 607,000.00 |
| Jun 30, 2025 | 607,000.00 |
| Mar 31, 2025 | 607,000.00 |
| Dec 31, 2024 | 607,000.00 |
| Sep 30, 2024 | 607,000.00 |
| Jun 30, 2024 | 607,000.00 |